Correction to: Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures.

Autor: Teng YHF; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Quah HS; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Suteja L; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Dias JML; Hutchison/MRC Research Centre, MRC Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, CB2 0XZ, UK., Mupo A; Babraham Research Institute, Cambridge, CB22 3AT, UK., Bashford-Rogers RJM; Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Dr, Headington, Oxford, OX3 7BN, UK., Vassiliou GS; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge Biomedical Campus, Puddicombe Way, Cambridge, CB2 0AW, UK., Chua MLK; Duke-NUS Medical School, Singapore, Singapore.; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan DSW; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Lim DWT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.; Institute of Molecular and Cell Biology, A-STAR, Singapore, Singapore., Iyer NG; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore. gopaliyer@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. gopaliyer@singhealth.com.sg.; Department of Head and Neck Surgery, National Cancer Centre Singapore, Singapore, Singapore. gopaliyer@singhealth.com.sg.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Apr; Vol. 71 (4), pp. 999.

Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities.

Autor: Chua KP; Genome Institute of Singapore, Singapore, Singapore., Teng YHF; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Cancer Therapeutics Research Laboratory, National Cancer Center Singapore, Singapore, Singapore., Tan AC; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School Singapore, Singapore., Takano A; Division of Pathology, Singapore General Hospital, Singapore, Singapore., Alvarez JJS; Genome Institute of Singapore, Singapore, Singapore., Nahar R; Genome Institute of Singapore, Singapore, Singapore., Rohatgi N; Genome Institute of Singapore, Singapore, Singapore., Lai GGY; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Aung ZW; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Yeong JPS; Division of Pathology, Singapore General Hospital, Singapore, Singapore., Lim KH; Division of Pathology, Singapore General Hospital, Singapore, Singapore., Naeini MM; Genome Institute of Singapore, Singapore, Singapore., Kassam I; Genome Institute of Singapore, Singapore, Singapore., Jain A; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Tan WL; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Gogna A; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore, Singapore., Too CW; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore, Singapore., Kanesvaran R; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Ng QS; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Ang MK; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Rajasekaran T; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Anantham D; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore., Phua GC; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore., Tan BS; Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore, Singapore., Lee YY; Genome Institute of Singapore, Singapore, Singapore., Wang L; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Teo ASM; Genome Institute of Singapore, Singapore, Singapore., Khng AJ; Genome Institute of Singapore, Singapore, Singapore., Lim MJ; Genome Institute of Singapore, Singapore, Singapore., Suteja L; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Toh CK; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Lim WT; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School Singapore, Singapore.; IMCB NCC MPI Singapore Oncogenome Laboratory, Institute of Molecular and Cell Biology, Singapore, Singapore., Iyer NG; Cancer Therapeutics Research Laboratory, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School Singapore, Singapore.; Division of Surgical Oncology, National Cancer Center Singapore, Singapore, Singapore., Tam WL; Genome Institute of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore., Tan EH; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore., Zhai W; Genome Institute of Singapore, Singapore, Singapore.; Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming, China., Hillmer AM; Genome Institute of Singapore, Singapore, Singapore.; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Skanderup AJ; Genome Institute of Singapore, Singapore, Singapore. daniel.tan.s.w@singhealth.com.sg skanderupamj@gis.a-star.edu.sg., Tan DSW; Genome Institute of Singapore, Singapore, Singapore. daniel.tan.s.w@singhealth.com.sg skanderupamj@gis.a-star.edu.sg.; Division of Medical Oncology, National Cancer Center Singapore, Singapore, Singapore.; Cancer Therapeutics Research Laboratory, National Cancer Center Singapore, Singapore, Singapore.; Duke-NUS Medical School Singapore, Singapore.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Nov 01; Vol. 27 (21), pp. 5939-5950. Date of Electronic Publication: 2021 Jul 14.